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A B S T R A C T   
Impulse control disorder is a prevalent side-effect of Parkinson’s disease (PD) medication, with a strong negative 
impact on the quality of life of those affected. Although impulsivity has classically been associated with response 
inhibition deficits, previous evidence from PD patients with impulse control disorder (ICD) has not revealed 
behavioral dysfunction in response inhibition. In this study, 18 PD patients with ICD, 17 PD patients without this 
complication, and 15 healthy controls performed a version of the conditional Stop Signal Task during functional 
magnetic resonance imaging. Whole-brain contrasts, regions of interest, and functional connectivity analyses 
were conducted. Our aim was to investigate the neural underpinnings of two aspects of response inhibition: 
proactive inhibition, inhibition that has been prepared beforehand, and restrained inhibition, inhibition of an 
invalid inhibitory tendency. We observed that, in respect to the other two groups, PD patients with ICD exhibited 
hyperactivation of the stopping network bilaterally while performing proactive inhibition. When engaged in 
restrained inhibition, they showed hyperactivation of the left inferior frontal gyrus, an area linked to action 
monitoring. Restrained inhibition also resulted in changes to the functional co-activation between inhibitory 
regions and left inferior parietal cortex and right supramarginal gyrus. Our findings indicate that PD patients 
with ICD completed the inhibition task correctly, showing altered engagement of inhibitory and attentional 
areas. During proactive inhibition they showed bilateral hyperactivation of two inhibitory regions, while during 
restrained inhibition they showed additional involvement of attentional areas responsible for alerting and 
orienting.   
1. Introduction 
The ability to appropriately stop an ongoing motor response or 
refrain from inhibiting that response enables us to adapt to the envi-
ronment. Inhibitory control is the cognitive function responsible for 
those adaptive behaviors. More specifically, response inhibition refers to 
a motor form of inhibitory control. Its neural underpinnings are a right- 
lateralized network consisting of the anatomically connected (Aron 
et al., 2007a) presupplementary motor area (preSMA), inferior frontal 
gyrus (IFG), and subthalamic nucleus (STN) (Aron, 2011). Despite the 
right-lateralization of the stopping network, some left hemisphere 
recruitment, particularly of the left IFG, is typically observed (Aron 
et al., 2014; Criaud and Boulinguez, 2013; Swick et al., 2008, 2011). 
Response inhibition also requires attention and monitoring 
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resources, which can easily be confounded with inhibitory mechanisms. 
For this reason, a number studies have aimed to segregate the effects of 
response inhibition and attention (Criaud and Boulinguez, 2013; 
Hampshire et al., 2010; Meffert et al., 2016). Working alongside the 
stopping network, attentional mechanisms managed by the dorsal and 
ventral networks ensure a task can be completed without distractions. 
The dorsal network, comprising mostly bilateral areas, such as dorsal 
fronto-parietal regions (Corbetta et al., 2008), is responsible for main-
taining alertness, through the top-down allocation of attention. The 
ventral network, comprising right-lateralized frontoparietal areas, such 
as the IFG (Cabeza et al., 2008; Corbetta et al., 2008), is responsible for 
shifting attention when reorienting from one stimulus to another (Fan 
et al., 2005). Although segregated, the dorsal and ventral attentional 
networks interact to meet task demands. This flexible collaboration is 
orchestrated by the IFG and the middle frontal gyrus (Vossel et al., 
2014). 
When the stopping network functions deficiently, it can affect im-
pulse control abilities (Aron et al., 2007b), leaving patients unable to 
manage urges. This, in turn, can lead to socioeconomic, personal, and 
family problems that affect quality of life. This is the struggle that Par-
kinson’s disease (PD) patients experience if they develop Impulse Con-
trol Disorder (ICD). In PD patients, ICD is an adverse effect of 
dopaminergic treatment, which leads patients to experience problems 
regulating behaviors (American Psychiatric Association, 2013). Large 
cross-sectional studies estimate that between 13.6% and 40% of PD 
patients under dopaminergic medication will experience ICD (Antonini 
et al., 2017; Garcia-Ruiz et al., 2014; Sharma et al., 2015; Weintraub 
et al., 2010). The most common addictive behaviors that patients 
develop are compulsive buying, compulsive eating, pathological 
gambling, and compulsive sexual behaviors (Martini et al., 2018; 
Weintraub et al., 2009). Investigating how treatments affect the stop-
ping network will help us better understand how response inhibition 
mechanisms function in PD, especially PD- ICD patients, and in impul-
sive pathologies more generally. 
The effects of PD pathology on motor regions and movement initi-
ation have led to multiple studies examining response inhibition in PD 
patients without ICD (PD-noICD). Different aspects of inhibition have 
been studied, including reactive inhibition, the ability to stop once 
instructed, and proactive inhibition, the ability to prepare for inhibition 
beforehand. PD-noICD patients show inhibitory deficits in reactive and 
proactive inhibition (Gauggel et al., 2004; Mirabella et al., 2017; Obeso 
et al., 2014). However, early-stage PD patients show heterogeneous 
impairment, with evidence for impaired (Di Caprio et al., 2020) as well 
as unimpaired (Vriend et al., 2015) reactive inhibition, and normal 
proactive inhibition (Di Caprio et al., 2020). Results do not seem driven 
by the effects of medication, with patients showing impairment while 
they are in both ON and OFF states (Obeso et al., 2011). Yet, it is still 
unclear whether inhibitory deficits are linked to disease progression or 
to prolonged medication intake. The lateralization of the stopping 
network could also be altered by PD pathology, implicating bilateral 
structures to a greater extent (Mirabella et al., 2017). 
Going beyond the effects of PD pathology, the case of PD with ICD 
(PD-ICD) provides a study sample in which continuous dopamine intake 
alters patients’ ability to regulate behavior, triggering ICDs. Yet, few 
studies have assessed response inhibition in PD-ICD patients. Behav-
iorally, studies with PD-ICD patients have shown mixed results. It has 
been reported that PD-ICD patients i) stop initiated movements faster 
than matched PD-noICD patients and healthy controls (Claassen et al., 
2015); ii) behave like their control counterparts (Filip et al., 2018); and 
iii) respond more impulsively than PD-noICD controls (Meyer et al., 
2020). Meyer and colleagues (2020) also found abnormal beta activity 
in the SMA and precuneus during proactive inhibition in their PD-ICD 
group. To the best of our knowledge, the only functional magnetic 
resonance imaging (fMRI) study to date that has examined response 
inhibition in PD-ICD (Filip et al., 2018) found that, despite observing no 
differences in reactive inhibition between PD-ICD and PD-noICD groups 
ON dopaminergic medication, PD-ICD patients showed hypoactivation 
in frontal areas and the left caudate compared to PD-noICD and healthy 
control (HC) groups. Furthermore, compared to the other groups, the 
PD-ICD group showed reduced functional connectivity (FC) between the 
caudate nuclei and both the superior parietal lobe and insula. These 
alterations of co-activation strengthened the authors’ claim that changes 
associated with PD-ICD go beyond the stopping network. Remarkably, 
this study did not show functional activation or connectivity differences 
in areas of the stopping network. This could be due to a reactive inhi-
bition paradigm that was not sufficiently challenging to detect changes 
in this population. 
Although contradictory, most evidence leans towards a lack of 
behavioral impairment in PD-ICD compared to PD-noICD individuals in 
response inhibition (Claassen et al., 2015; Filip et al., 2018) and 
cognitive inhibition (Paz-Alonso et al., 2020), suggesting compensatory 
mechanisms in PD-ICD patients. Thus, in the present work, our goal was 
to investigate the neural correlates of response inhibition in patients 
with medication-induced increased impulsivity. We utilized a natural-
istic version of the demanding conditional Stop Signal Task (SST) in 
which we did not increase the level of difficulty to artificially force 
participants to fail. The SST paradigm is particularly challenging and 
differs from other classical response inhibition tasks because it requires 
the participant to stop an action that has already been initiated. This 
makes the SST particularly demanding for PD-ICD subjects, in contrast 
to the task used by Filip and colleagues in which a non-initiated action 
had to be inhibited (Filip et al., 2018). An fMRI study using the SST in 
healthy adults showed activation of the right IFG, right STN, and right 
preSMA (Aron et al., 2007a). We focused on two critical aspects of 
response inhibition – proactive and restrained inhibition – in PD patients 
with and without ICD. 
Proactive inhibition refers to the ability to prepare to inhibit (Aron, 
2011), which involves recruiting the stopping network before inhibition 
occurs. It has been proposed as a more valid measure of response inhi-
bition (Aron, 2011; Meyer et al., 2020) than reactive inhibition which 
does not involve preparation. Because of the taxing nature of our task, 
we expected PD-ICD patients would show changes in inhibitory regions 
as they strove to perform correctly. We also expected greater co- 
activation between the stopping network and the dorsal attention 
network responsible for maintaining an alerting state, since PD-ICD 
patients would need to maintain greater focus to perform successfully. 
Restrained inhibition is the ability to disengage from an invalid cue 
signaling inhibition and perform the motor response despite the incon-
gruence of the cue. While performing our task, participants encountered 
trials containing the salient stimulus they had learned to associate with 
inhibition. However, during restrained inhibition trials, they had to 
refrain from the learnt inhibition and execute the task (a button-press). 
This aspect of response inhibition is understood as the inhibition of an 
inhibitory action. Restrained inhibition has not been previously exam-
ined in PD-ICD patients. However, the fact that this group shows 
increased difficulty in regulating behavior (i.e., switching between rules, 
redirecting attention, and processing incongruent stimuli) suggests they 
may be particularly affected when attempting to restrain inhibition. We 
expected PD-ICD patients to show alterations in the stopping network as 
well as co-activation with areas in the ventral attentional network 
involved in reorienting attention and disengaging from invalid cues, and 
regions of the dorsal network that provide optimal focus on a task. The 
IFG might also be vital for restrained inhibition: the right IFG for stop-
ping and reorienting attention to relevant stimuli (Corbetta et al., 2008); 
the left for filtering out irrelevant actions (Chong et al., 2008). 
2. Materials and methods 
2.1. Participants 
The final sample comprised fifty participants: 18 PD-ICD patients, 17 
PD-noICD, and 15 HC matched on age, sex, education, and premorbid 
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intelligence (see supplementary materials for details on original sam-
ple). Nine additional participants were excluded: three participants (one 
PD-ICD and two HC) due to outlier performance (>2 SDs) on the con-
ditional SST task; three (two PD-ICD and one HC) for excessive head 
motion during fMRI scanning (see MRI data analysis for more details); 
and three (one PD-noICD and two HC) for problems related to con-
structing a functional mask due to motion during structural data 
acquisition. 
All PD patients were diagnosed according to the UK Parkinson’s 
Disease Society Brain Bank criteria. They were recruited from the 
Movement Disorders Unit of the Hospital Universitario Donostia, Spain. 
Inclusion criteria for the PD-ICD group included at least one ICD not 
present either at the time of PD diagnosis or before the initiation of 
dopamine replacement therapy. The ICD diagnosis was confirmed by a 
neurologist and a psychiatrist based on the fifth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (American Psychiatric As-
sociation, 2013) criteria and the Questionnaire for Impulsive- 
Compulsive Disorders in PD (Weintraub et al., 2009). Every PD-ICD 
patient scored above the cut-off for their ICD subtype in the 
Questionnaire for Impulsive-Compulsive Disorders in PD Rating Scale 
(QUIP-RS) (Weintraub et al., 2012). Exclusion criteria for PD patients 
were dementia (Emre et al., 2007) and mild cognitive impairment ac-
cording to the Movement Disorders Society Task Force criteria (Level II) 
(Litvan et al., 2012), presence of dyskinesias, brain surgery, or previous 
diagnosis of PD-ICD that had been resolved at recruitment. HC partici-
pants were recruited from the Basque Center on Cognition, Brain and 
Language (BCBL)’s participants’ pool. Exclusion criteria for HC partic-
ipants was the presence of any neurological condition or any type of 
cognitive impairment. 
The three groups underwent a comprehensive neuropsychological 
assessment (see supplementary Table 1 for more details). This study was 
approved by the Gipuzkoa Clinical Research Ethics Committee. All 
participants were right-handed and provided written informed consent 
before joining the experiment. 
2.2. MRI data acquisition 
Functional and structural images were collected at the BCBL’s 3T 
Fig. 1. Schematic representation of the conditional SST task by (A) conditions and (B) contrasts of interests; and percentage of correct responses by (C) conditions 
and (D) contrasts of interests. Error bars represent 95% confidence interval. PD-ICD = Parkinson’s Disease with Impulse Control Disorder, PD-noICD = Parkinson’s 
Disease patients with no Impulse Control Disorder, HC = healthy controls. 
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Siemens Magnetom TIM Trio MRI scanner using a 32-channel head coil. 
PD participants underwent scanning under the effect of dopaminergic 
medication. See Supplementary Data for additional information on MRI 
data acquisition. 
2.3. Functional magnetic resonance imaging paradigm: Conditional Stop- 
Signal task 
In the scanner, participants completed a conditional variation of the 
traditional SST (Logan et al., 1984). This conditional SST (see Fig. 1A) 
comprised 75% Go and 25% Stop trials. All trials began with a grey 
fixation circle. After 500–5000 ms, a green arrow appeared, pointing 
either left or right. Participants were instructed to press the button 
corresponding to the direction of the arrow, as quickly as possible. Prior 
to the scanning, each participant had completed a practice session, 
learning that one direction (left or right) was non-critical, while the other 
was critical (directions counterbalanced across participants). In Stop 
trials, a red arrow, appeared 100–250 ms (varying by 50 ms intervals) 
after – always pointing in the same direction as the green arrow. 
Importantly, on critical Stop trials, participants had to inhibit their 
initiated response as soon as the red arrow appeared, while on non- 
critical Stop trials, they had to ignore the red arrow and respond nor-
mally. After each trial, a fixation cross appeared on screen for 500 ms. To 
examine PD-ICD patients’ impulsivity in a naturalistic setting where 
they were not forced to fail, all participants were presented with the 
same inter-stimulus-intervals between the green and red arrows in Stop 
trials. This constitutes a more naturalistic measure of response inhibi-
tion. Nevertheless, because we did not adjust the inter-stimulus-interval 
to accommodate participants’ individual performance levels, we could 
not calculate the stop signal response time, a measure typically 
employed in the SST literature. Instead, we were used accuracy mea-
sures to determine performance impairments. The task design allowed 
us to measure two aspects of inhibition (see Fig. 1B): Proactive Inhibi-
tion was calculated by subtracting correct non-critical Go trials, which 
entailed neither preparation to inhibit nor inhibition, from critical Stop 
trials, which required both preparation to inhibit and inhibition [critical 
Stop minus non-critical Go]. To execute proactive inhibition, partici-
pants needed to flexibly switch between the rules for critical and non- 
critical trials, prepare for the possible need to inhibit if a green arrow 
pointed in the critical direction, and stop the motor execution when the 
red arrow appeared in critical Stop trials. Restrained inhibition was 
measured by subtracting correct non-critical Go trials from correct non- 
critical Stop trials, in which participants had to ignore an invalid 
inhibitory stimulus [non-critical Stop minus non-critical Go]. To execute 
restrained inhibition correctly, participants needed to flexibly switch 
between the rules for critical and non-critical trials. Further, in non- 
critical Stop trials they needed to refrain from inhibiting the button- 
press, this is, stop the inhibitory action, and finish executing the 
movement as quickly as possible. 
2.4. Behavioral data analyses 
Behavioral results were analysed with a 3 (Group: PD-ICD, PD- 
noICD, HC) by 2 (Direction: critical, non-critical) by 2 (Condition: Go, 
Stop) mixed-model analysis of variance (ANOVA), run on the percent of 
correct responses in each condition on the SST task. Given our specific 
interest in focusing on proactive and restrained inhibition, we ran 
separate one-way ANOVAs with the factor Group and the absolute 
values of the subtraction between trials for Proactive Inhibition (|critical 
Stop - non-critical Go|), and Restrained Inhibition (|non-critical Stop - 
non-critical Go|), with accuracy as the dependent measure. 
Participants had to withhold their response in one of the main con-
ditions of interest–critical Stop. Analyzing response time (RT) data 
without including that key condition either in the whole-experimental 
design or the Proactive/Restrained Inhibition analyses would have 
given us an incomplete, possibly biased, result. Therefore, we focused 
exclusively on accuracy results. However, to ensure there were no dif-
ferential speed-accuracy trade-off between groups that could bias our 
results, with one group applying a different strategy than the other 
groups, we additionally computed an adapted version of the Balanced 
Integration Score (BIS) (Liesefeld et al., 2015; Liesefeld and Janczyk, 
2019). The BIS removes any trade-off effect from the accuracy scores. 
For information on RT see supplementary Table 2. 
2.5. MRI data analyses 
SPM8 was used to perform standard preprocessing routines and 
analysis. See Supplementary Data for further details on MRI data pre-
processing and analyses. 
Statistical analyses were performed on individual participant’s data 
applying the general linear model. The fMRI time series data were 
modeled as a series of events convolved with a canonical hemodynamic 
response function. Five fMRI experimental conditions were modeled 
(critical Go correct, non-critical Go correct, critical Stop correct, non- 
critical Stop correct, and critical Stop incorrect), with each trial 
modeled as an event and time locked to the presentation of the first 
stimulus in each trial. The study followed a 3 (Group: PD-ICD, PD- 
noICD, HC) by 5 (Conditions: critical Go, non-critical Go, critical Stop, 
non-critical stop, Critical stop incorrect) experimental design. We had 
two main comparisons of interest comprising correct responses: Proac-
tive Inhibition (i.e., critical Stop – non-critical Go), and Restrained Inhi-
bition (i.e., non-critical Stop – non-critical Go). These contrasts were 
examined by means of whole-brain contrasts, region-of-interest (ROI) 
analyses, and FC analyses. Depiction of FC analyses was done with 
BrainNet Viewer (Xia et al., 2013). 
3. Results 
3.1. Demographic and clinical data 
There were no differences between groups in demographic data (see 
Table 1). PD-noICD and PD-ICD groups did not differ in disease duration, 
dopaminergic medication, motor severity and cognitive outcomes (see 
supplementary Table 1). 
3.2. Behavioral results 
The 3 (Group) by 2 (Direction) by 2 (Condition) mixed-model 
ANOVA on the percentage of correct responses revealed main effects 
of Direction, (F1,43 = 37.36, p < 0.001, ηp2 = 0.46) and Condition, (F1,43 
= 117.79, p < 0.001, ηp2 = 0.73), subsumed by a statistically significant 
Direction by Condition interaction, (F1,43 = 11.42, p = 0.002, ηp2 =
0.21). There were no main or interactive effects of Group (Fs < 1.1, p >
0.1, ηp2 ≤ 0.05). Simple-effect post-hoc analyses examining the Direction 
by Condition interaction showed trial differences associated with task 
difficulty (non-critical Go = critical Go > non-critical Stop > critical 
Stop, ps < 0.02) (see Fig. 1C). Separate one-way ANOVAs for the con-
trasts Proactive and Restrained inhibition did not reveal Group effects 
(Fs < 2, p > 0.1, ηp2 < 0.1) (see Fig. 1D). We re-ran the previously 
described analyses with the BIS of the conditions and contrasts but again 
found no main or interactive effects of the factor Group (Fs < 2.2, p >
0.12, ηp2 ≤ 0.09). 
3.3. MRI results 
3.3.1. Whole-brain analysis 
We computed a whole-brain functional contrast for all the task 
conditions versus the baseline condition (All Conditions > Null) to 
identify regions activated during the task across all participants (see 
Fig. 2A). We observed recruitment of right-lateralized nodes of the 
stopping network (IFG, preSMA, STN) as well as their contralateral 
homologues in all participants. We computed the same contrast 
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separately for each group and observed that the two PD groups tended to 
show left-lateralized extended activation (see Fig. 2B). The bilateral 
recruitment during inhibitory control in PD patients resembles a previ-
ous claim (Mirabella et al., 2017) and highlights the importance of 
examining not only the right-lateralized nodes from the classical 
inhibitory control network, but also their left-lateralized homologues. 
3.3.2. ROI analyses 
3.3.2.1. Proactive inhibition. The 3 (Group) by 2 (Hemisphere) mixed- 
model ANOVA showed a main effect of Group for the percent signal 
change of the bilateral preSMA (F2,46 = 6.74, q = 0.009, ηp2 = 0.23) and 
bilateral IFG (F2,46 = 3.85, q = 0.043, ηp2 = 0.14). Post-hoc tests 
revealed hyperactivation of the preSMA for the PD-ICD group relative to 
both the PD-noICD (t33 = 3.29, q = 0.007, d = 0.47) and the HC (t31 =
3.01, q = 0.008, d = 0.43) groups, as well as hyperactivation of the IFG 
for the PD-ICD group compared to the PD-noICD group (t33 = 2.59, q =
0.043, d = 0.37). No group differences were observed for the STN (see 
Fig. 3A). 
This analysis also showed a main effect of Hemisphere for the percent 
signal change of the preSMA (F2,46 = 21.65, q < 0.001, ηp2 = 0.32), the 
IFG (F2,46 = 62.98, q < 0.001, ηp2 = 0.58), and the STN (F2,46 = 4.51, q =
0.039, ηp2 = 0.09), with right hemisphere ROIs showing greater acti-
vation than their left hemisphere homologues. 
For PD-ICD patients, we observed a significant negative correlation 
between preSMA activation and their QUIP score (rho = -0.49, p =
0.041). However, this correlation did not survive multiple comparisons 
correction (q = 0.082). We found no other significant correlations. 
3.3.2.2. Restrained inhibition. The analysis revealed a statistically sig-
nificant Group by Hemisphere interaction for the percent signal change 
of the IFG (F2,46 = 7.92, q < 0.001, ηp2 = 0.26). To follow-up on this 
interaction we performed between-group ANOVAs separately for the left 
and right IFG. We found an effect only for the left IFG (F2,46 = 5.87, q =
0.01, ηp2 = 0.2), with post-hoc tests revealing hyperactivation of the left 
IFG in the PD-ICD group compared to the PD-noICD (t32 = 2.78, q =
0.013, d = 0.95) and HC groups (t30 = 3.13, q = 0.013, d = 1.02) (see 
Fig. 3B). 
3.3.3. Functional connectivity analysis 
A previous study suggested that activation changes during inhibition 
are present beyond the stopping network in PD-ICD patients (Filip et al., 
2018). To examine the FC of inhibitory regions and their homologues 
with other brain areas, we conducted whole-brain functional connec-
tivity analyses seeding the nodes of the traditional stopping network and 
Table 1 
Demographics and clinical characteristics of the sample.   
PD-ICD PD-noICD HC p 
n = 18 n = 17 n = 15 
Age 63.33 (8.24) 61.65 (9.21) 61.87 
(9.77) 
0.837a 
Sex, male (%) 16 (88.90%) 14 (82.40%) 14 
(93.30%) 
0.837b 
Education (years) 12.50 [7–20] 11 [7–20] 20 [5–20] 0.319c 
Premorbid IQ (WAIS- 
III Vocabulary) 











H&Y stage 2 [1.5–3] 2 [1–3] – 0.837b 










HADS score 6.50 [1–25] 4 [1–10] 6 [1–16] 0.148c 
QUIP-RS score 16.50 [7–46] 0 [0–0] – >0.001e 
Note: Values expressed in Mean (SD) for normally distributed variables, in Median 
[Range] for other variables. P-values represent FDR-adjusted p-values. 
Abbreviations: IQ = Intelligence Quotient; WAIS-III = Wechsler Adult Intelli-
gence Scale-III; UPDRS = Unified Parkinson’s Disease Rating Scale; H&Y =
Hoehn and Yahr scale; LEDTOTAL = Total levodopa equivalent daily dose was 
calculated according to the formula described by Tomlinson et al. (2010); 
LEDDA = Levodopa equivalent daily dose of dopamine agonist was calculated 
using the same formula; HADS = Hospital Anxiety and Depression Scale; QUIP- 
RS = Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease- 
Rating Scale. 
a One factor ANOVA. 
b Chi-Square Likelihood Ratio. 
c Kruskall-Wallis. 
d Two-sample T-test. 
e U Mann Whitney. 
Fig. 2. Brain renderings showing activations for the whole brain contrast All >
Null for (A) all participants at a statistical threshold of p < 0.05 voxel FWE- 
corrected, and for each study group (B), p < 0.001 voxel-level extent 
threshold, p < 0.05 cluster-level FWE corrected. 
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their left counterparts for the contrasts of interest: Critical Stop vs Null 
and Non-critical Stop vs Null. 
3.3.3.1. Proactive inhibition. No between-group differences in FC 
emerged using the IFG, preSMA, and STN left and right seeds. 
3.3.3.2. Restrained inhibition. Stronger left IFG-inferior parietal (IPC)/ 
supramarginal (SMG) FC (maxima at MNI coordinates –33, − 52, 43, t =
5.99) was observed for the PD-ICD compared to the PD-noICD group (see 
Fig. 4A). The left IPC and SMG are areas associated with the dorsal 
attention network. Also, tighter right IFG-postcentral/SMG FC (maxima 
at 51, − 10, 28, t = 6.17) was found for the PD-ICD compared to the PD- 
noICD group (see Fig. 4B). The right SMG has been linked to the ventral 
attention network. 
We also found reduced right preSMA-putamen/insula (maxima at 
33, − 13, 1, t = 5.06) (see Fig. 4C) and right STN-precuneus (maxima at 
9, − 49, 37, t = 4.49) FC for the PD-ICD compared to the PD-noICD group 
(see Fig. 4D). 
4. Discussion 
In the current study, we employed a demanding response inhibition 
task, with sustained natural difficulty levels. By not forcing participants 
to fail, we were able to observe unbiased performance. PD-ICD patients 
Fig. 3. ROI analyses for Proactive and Restrained Inhibition. (A) Proactive inhibition showed a group effect for preSMA and IFG. (B) Restrained inhibition showed a 
group by hemisphere interaction. Significance of group effects shown in graphs. Error bars represent 95% confidence interval. 
Fig. 4. Functional whole-brain connectivity during Restrained Inhibition. Compared to PD-noICD participants, PD-ICD patients showed increased functional 
coupling of the left IFG (A) and right IFG (B) with parietal regions, plus decreased functional co-activation of the right preSMA (C) with putamen/insula and right 
STN (D) with precuneus. 
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presented no behavioral impairments relative to their PD-noICD and HC 
counterparts, as expected from previous evidence (Claassen et al., 2015; 
Filip et al., 2018). However, functional correlates linked to proactive 
and restrained inhibition suggested that PD-ICD resolved inhibitory 
demands differently from their PD-noICD and HC counterparts. 
While performing proactive inhibition, regions of the right- 
lateralized stopping network showed the highest activation across all 
groups. However, the PD-ICD group showed strong right-lateralized 
hyperactivation as well as hyperactivation of left-lateralized homo-
logues, previously not considered to form part of the stopping network. 
This bilateral involvement might indicate that PD-ICD subjects had to 
exert greater effort during proactive inhibition than the other groups 
but, since this was not entirely resolved by right-lateralized hyper-
activation, they then recruited the stopping network bilaterally. 
Together with the lack of behavioral impairment and the absence of 
differences in functional connectivity, these patterns of hyperactivation 
suggest that PD-ICD participants engage in proactive inhibition by 
strongly activating the bilateral stopping network and that this chal-
lenge is resolved at the regional level without increasing recruitment of 
attentional resources. 
One of these bilaterally hyperactivated areas is the IFG. The right IFG 
forms part of both the stopping network (Aron et al., 2007a) and the 
ventral attention network (Corbetta et al., 2008). As stated in the 
Introduction, a role for the left IFG – alongside other regions – in inhi-
bition is still challenged by some authors (Aron et al., 2014) but 
accepted by others (Criaud and Boulinguez, 2013; Meffert et al., 2016; 
Swick and Chatham, 2014). The left IFG is known to be responsible for 
evaluating and selecting appropriate actions (Pobric and Hamilton, 
2006; Swick et al., 2008). This attentional function could be recruited 
when inhibition must be prepared in a critical trial and then applied if a 
stop signal appears. The other hyperactive region, the preSMA, is known 
to be involved in action selection (Mueller et al., 2007; Tanji, 1994), 
which is important when deciding whether a motor action should be 
halted or not. The role of both IFG and preSMA in implementing inhi-
bition was previously underscored by a transcranial magnetic stimula-
tion study (Obeso et al., 2013a). In this study, PD patients showed 
contralateral recruitment as a compensatory mechanism for malfunction 
of the stopping network (Obeso et al., 2013b). Specifically, the authors 
reported evidence for contralateral compensatory engagement of the left 
IFG and left preSMA – but not the STN. Similarly, we did not observe 
differential activation of the STN in the PD-ICD group. While these pa-
tients exhibited evidence of increased demand in regions responsible for 
detecting the need to inhibit (Aron, 2011) (i.e., preSMA, IFG), they were 
still able to execute motor inhibition correctly, showing normal demand 
in the region that executed the order (i.e., STN). In fact, PD-ICD patients 
are known to stop faster than controls (Claassen et al., 2015), and 
therefore execute inhibitory commands correctly. Taken together with 
our findings, this suggests that PD-ICD patients find preparation to 
inhibit (not necessarily inhibition per se), challenging. Thus, it is regions 
responsible for detecting and sending the inhibitory command to the 
STN that become hyperactivated. 
As opposed to proactive inhibition, restrained inhibition did not 
differentially activate any of the classical components of the right- 
lateralized stopping network as a function of group. Nonetheless, in 
PD-ICD patients, relative to PD-noICD and HCs, restrained inhibition 
was associated with hyperactivation of the left IFG. As discussed above, 
the left IFG has been linked to monitoring relevant and irrelevant actions 
(Milham et al., 2001; Swick et al., 2008). Patients with ICD might be 
particularly challenged when they are presented with invalid stop cues 
and have to decide whether to respond or instead withhold movement. 
This need to supervise the action of responding or withholding could 
explain the hyperactivation of the left IFG. 
We found functional connectivity changes were only associated with 
restrained inhibition. Compared to the PD-noICD group, PD-ICD patients 
showed greater co-activation between the IFG, relevant not only for 
inhibition but also for monitoring and reorienting attention, and areas 
related to: alerting (left IPC and SMG) (Cabeza et al., 2008); reorienting 
attention (right SMG) (Chica et al., 2013; Corbetta et al., 2008) and 
motor sensation (postcentral gyrus). Moreover, it has been suggested 
that components of the dorsal and ventral networks interact with each 
other, that this interaction is led by frontal areas such as the IFG, and 
that both networks are required to shift attention (Vossel et al., 2014). 
The role of attention in response inhibition tasks is an important issue. 
Many experimental paradigms could lead to confounds between acti-
vation related to attention and that related to inhibition per se. The IFG 
has been at the center of this debate as it is likely involved in both 
functions (Hampshire and Sharp, 2015; Padmala and Pessoa, 2010). In 
contrast to PD-noICD patients, PD-ICD patients show increased FC be-
tween the IFG and components of the dorsal and ventral networks. This 
suggests they recruit additional attentional resources to perform 
restrained inhibition when task demands increase. PD-ICD patients 
asked to make a motor decision while also coping with a contradictory 
irrelevant stimulus likely experience greater difficulty maintaining 
attention, shifting focus when disengaging from the invalid stop stim-
ulus to return to the button-press task, and processing feedback on that 
motor response. 
However, relative to PD-noICD patients, PD-ICD patients showed 
weaker functional co-activation between the right preSMA, involved in 
motor planning, and both the right posterior insula and putamen – 
tightly connected areas (Chikama et al., 1997), associated with so-
matosensory awareness (Chang et al., 2013) and motor control 
(Lehéricy et al., 2006), respectively. This reduced functional co- 
activation for PD-ICD relative to PD-noICD patients could reflect PD- 
noICD patients’ well-established difficulty in initiating movement 
(Dietz et al., 1990), which is known to alter preSMA activity even at an 
early stage of PD disease manifestation (Eckert et al., 2006). PD-ICD 
patients’ impulsivity might alleviate movement initiation difficulties, 
eliminating the need for strong co-activation of areas involved in plan-
ning a movement and sensorimotor processing. Yet, further studies 
would be needed to test this claim. Finally, PD-ICD patients showed 
weaker co-activation than PD-noICD subjects between the right STN and 
the right precuneus. A previous study suggested increased co-activation 
between those regions –right STN and right precuneus– for PD-noICD 
compared to HC participants during resting state (Fernández-Seara 
et al., 2015). We found, however, this abnormal connectivity was 
reduced in PD-ICD patients. This discrepancy might be due to the 
increased impulsivity of PD-ICD patients and the fact that the BOLD 
signal was not obtained at rest but during the inhibition of an inhibitory 
signal, in sum, facilitation of the action (the button press). Such facili-
tation is associated with reduced FC between the STN and the pre-
cuneus, which is responsible for both integration of perceptual 
information (Cavanna and Trimble, 2006) and cue reactivity (Starcke 
et al., 2018). This finding is in keeping with the observation that STN 
stimulation, which reduces STN activity and therefore its FC, speeds up 
patients’ decisions under conflict conditions (Ballanger et al., 2009; 
Frank et al., 2007) such as restrained inhibition. In fact, although not 
significant, in our experiment, PD-ICD patients showed higher accuracy 
in restrained inhibition, probably due to facilitated inhibition of the 
irrelevant stop signal, whereas the three groups behaved similarly dur-
ing proactive inhibition (Fig. 1D). This interesting finding indicates that 
it is easier for PD patients with abnormal impulsivity to ignore inhibition 
signals than to obey them, an effect linked to the STN. This effect would 
also help explain why PD patients make rapid and impulsive decisions 
under high-conflict conditions during subthalamic stimulation (Bal-
langer et al., 2009; Frank et al., 2007); with impulsivity appearing to be 
a side-effect of such stimulation (Mosley et al., 2020). 
To our knowledge, no previous study has examined the functional 
correlates of different aspects of response inhibition in PD-ICD. How-
ever, our results should be considered bearing some limitations in mind. 
Firstly, the small sample size might have decreased the sensitivity of our 
analysis to detect further between-group differences. Secondly, all PD 
patients were deliberately assessed under medication to ensure optimal 
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scanning – this was important because ICD in PD is associated with 
dopaminergic treatment. There were, however, no differences in the 
dosage of antiparkinsonian medication between PD groups. Future 
studies should examine different aspects of response inhibition and 
attention in similar samples, for instance, manipulating task difficulty 
and/or including distractor stimuli across conditions. This could answer 
remaining questions, such as: Which aspects of inhibition impose higher 
demands on PD-ICD than PD-noICD patients? Do these demands force 
PD-ICD patients to recruit additional attentional resources during 
response inhibition? What influence do alerting and orienting mecha-
nisms exert on PD-ICD patients’ ability to inhibit a response? And, does 
task difficulty play a role in the performance of PD-ICD patients? 
4.1. Conclusions 
This study is the first to address functional alterations in PD-ICD 
patients by examining different aspects of inhibition. Subjects per-
formed a taxing response inhibition task, in which participants were 
required to stop an ongoing action or instead to finalize a movement. 
The PD-ICD group performed these tasks normally, but they used 
different mechanisms than either of the control groups to execute both 
aspects of inhibition. During proactive inhibition, PD-ICD patients 
hyperactivated a more bilateral network than their control counterparts. 
During restrained inhibition, PD-ICD patients activated the left IFG to a 
greater extent and recruited additional attentional resources, while also 
showing reduced co-activation between the right STN and precuneus. 
Therefore, the two aspects of inhibition assessed here presented specific 
challenges for the PD-ICD group, as reflected by differences in the 
functional correlates of inhibition. 
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T. Esteban-Peñalba et al.                                                                                                                                                                                                                      
NeuroImage: Clinical 32 (2021) 102822
9
Fan, J., McCandliss, B., Fossella, J., Flombaum, J., Posner, M., 2005. The activation of 
attentional networks. NeuroImage 26 (2), 471–479. https://doi.org/10.1016/j. 
neuroimage.2005.02.004. 
Fernández-Seara, M.A., Mengual, E., Vidorreta, M., Castellanos, G., Irigoyen, J., Erro, E., 
Pastor, M.A., 2015. Resting state functional connectivity of the subthalamic nucleus 
in Parkinson’s disease assessed using arterial spin-labeled perfusion fMRI. Hum. 
Brain Mapp. 36 (5), 1937–1950. https://doi.org/10.1002/hbm.22747. 
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